MARKET

OBX

OBX

Obsidian Therapeutics Inc
NASDAQ
13.23
-1.20
-8.32%
After Hours: 13.46 +0.23 +1.74% 16:06 11/03 EST
OPEN
14.23
PREV CLOSE
14.43
HIGH
14.97
LOW
13.01
VOLUME
626.85K
TURNOVER
--
52 WEEK HIGH
49.97
52 WEEK LOW
11.52
MARKET CAP
817.26M
P/E (TTM)
0.1007
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OBX last week (1026-1030)?
Weekly Report · 1d ago
Russell 2000 estimated to add 107 stocks in December rebalance - Stephens
Seeking Alpha · 5d ago
Weekly Report: what happened at OBX last week (1019-1023)?
Weekly Report · 10/26 10:34
Weekly Report: what happened at OBX last week (1012-1016)?
Weekly Report · 10/19 10:34
Weekly Report: what happened at OBX last week (1005-1009)?
Weekly Report · 10/12 10:41
Weekly Report: what happened at OBX last week (0928-1002)?
Weekly Report · 10/05 10:40
Obsidian Therapeutics To Present Updated Data In Patients With Immune-Checkpoint Inhibitor-Resistant Advanced Melanoma From Its Phase 1 Study And The Phase 1/2 Agni-01 Multicenter Study Of Amsokigene Autoleucel
Benzinga · 10/02 13:09
Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting
Barchart · 10/02 08:05
More
About OBX
Obsidian Therapeutics, Inc. is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered TIL cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE technology is designed to regulate the timing and level of protein function by using FDA-approved small-molecule drugs. Its lead clinical program, OBX-115, is an investigational TIL cell therapy engineered to express membrane-bound IL15 (mbIL15), which is designed to support TIL activity. Its cytoDRiVE discovery platform has identified a library of internally discovered drug-responsive domains (DRDs) of varying sizes and intended purposes and enables rapid optimization of regulatable and functional proteins in any cell type. It has developed a synthetic biology engineering toolkit that supports the design and optimization of a range of therapeutic proteins, including but not limited to type I/II membrane proteins, and membrane-bound cytokines.

Webull offers Obsidian Therapeutics, Inc stock information, including NASDAQ: OBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OBX stock methods without spending real money on the virtual paper trading platform.